Supplemental material
Drug Delivery
Volume 26, 2019 - Issue 1
Related Research Data
Contraceptive vaginal rings: a review
Source:
Elsevier BV
Anastrozole: a selective aromatase inhibitor for the treatment of breast cancer
Source:
Oxford University Press (OUP)
A Review of its Use in the Management of Postmenopausal Women with Advanced Breast Cancer
Source:
Springer Science and Business Media LLC
Vaginal absorption of insulin in the rat: effect of penetration enhancers on insulin uptake and mucosal histology.
Source:
Springer Science and Business Media LLC
Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial
Source:
Oxford University Press (OUP)
Anastrazole and oral contraceptives: a novel treatment for endometriosis
Source:
Elsevier BV
The Effect of Drug Content Reduction on the In Vitro and In Vivo Properties of Levonorgestrel-Releasing Intravaginal Rings
Source:
Elsevier BV
Contraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetate.
Source:
Elsevier BV
Why consider vaginal drug administration
Source:
Elsevier BV
The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability.
Source:
Elsevier BV
Characterization of anastrozole effects, delivered by an intravaginal ring in cynomolgus monkeys
Source:
Oxford University Press (OUP)
Arimidex ® : A potent and selective fourth-generation aromatase inhibitor
Source:
Springer Science and Business Media LLC
ESHRE guideline for the diagnosis and treatment of endometriosis
Source:
Oxford University Press (OUP)
Pharmacokinetics of Etonogestrel and Ethinylestradiol Released from a Combined Contraceptive Vaginal Ring
Source:
Springer Science and Business Media LLC
In vitro release properties of etonogestrel and ethinyl estradiol from a contraceptive vaginal ring
Source:
Elsevier BV
Linking provided by
